Next Quarterly Earnings
Date confirmed from the official Chinese exchange disclosure timetable.
Shenzhen Hepalink Pharmaceutical Group A is a leading global biotechnology company based in China. It specializes in the development and production of heparin active ingredients and innovative drugs for oncology, autoimmune diseases, and complex therapies.
Date confirmed from the official Chinese exchange disclosure timetable.
Shenzhen Hepalink Pharmaceutical Group A is scheduled to report its next quarterly earnings on 08/29/2026.
Shenzhen Hepalink Pharmaceutical Group A last reported quarterly earnings on 4/29/2026 (Q1 2026). Earnings per share (EPS) came in at 0.13 CNY.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.